×
Skip to content
ShareCafe

  • Home
  • Shares
  • Financial Products
  • Video
  • Contributors
  • Community
  • About us
  • Facebook
  • Twitter
  • YouTube
  • RSS
Main Menu

Tag: SHV

Broker News

SHV – Citi rates the stock as Buy

August 16, 2021 - by Broker News

Citi retains its Buy rating and $8.10 target price.

Read More
Commodities / Markets / Shares

Almond Demand Leads to Bumper Crop for Select

July 28, 2021July 28, 2021 - by Glenn Dyer

The improvement in the outlook for global almond prices and demand has seen Australian grower Select Harvests upgrade its expectations for its 2021 crop by more than 20%.

Read More
Markets / Shares

Discourse from the Bourse

May 30, 2021May 31, 2021 - by Glenn Dyer

A fair bit going on at the moment, here are a few developing stories from over the weekend we thought you might like updates on, involving PEXA / LNK, ING, SHV, TAH and FMG.

Read More
Markets / Shares

Sunny Outlook For Select Harvests

April 1, 2021 - by Eva Brocklehurst

Despite the NSW floods almond harvest volumes at Select Harvests are unchanged, although softer prices have driven a reduction in earnings forecasts.

Read More
Shares

Strong Crop Not Enough To Save Select Harvests Dividend

May 26, 2020May 26, 2020 - by Glenn Dyer

Shares in the ASX-listed almond producer Select Harvests have been cracked by investors after the company released a weak first-half result and cut its interim dividend.

Read More
Shares

When Market Volatility Is Irrelevant

December 6, 2019December 6, 2019 - by Greg Tolpigin

A strategy focused on actual businesses with momentum can repel market volatility. Importantly it can help you ride out any volatility because you understand that a “tweet” doesn’t translate to any effect on profits.

Read More
Shares

Buoyant Outlook For Select Harvests

December 4, 2019December 4, 2019 - by Eva Brocklehurst

Select Harvests has used strong cash flow over FY19 to pay down all debt and underpin production growth for the future.

Read More
Broker News

SHV – UBS rates the stock as Buy

December 2, 2019 - by Broker News

FY19 results were ahead of UBS estimates at both the earnings (EBIT) and net profit level. Strong cash flow has allowed the company to pay down all debt and provides for a material future growth option.

Read More
Commodities / Shares

Dipping Into Water Stocks

September 19, 2018September 19, 2018 - by Tim Boreham

The dry conditions in many of the key farming regions highlight the importance of water security for our listed agricultural plays. When it comes to water rights, some are in a better position than others.

Read More
Shares

Select Harvests Rejects UAE Takeover Bid

October 10, 2017 - by Glenn Dyer

Just as Accord is attempting to ‘hug’ Mantra with a fat ‘non-binding, indicative offer, so an attempt to try and inveigle Select Harvests the same way has failed for a Middle Eastern investor.

Read More
Shares

Almonds Very Tasty For Select Harvests

February 27, 2015 - by Glenn Dyer

Another mid cap with a solid interim out yesterday was Select Harvests (SHV) which boosted underlying profit 17% to $21.5 million for the six months to December.

Read More
  • FNN Video Test 1
  • Chinese Property Sector Slip Slidin’ Away
  • Nuggets Galore from the Local Resources Sector
  • The Falls in Share Markets – the Bad News and the Good
  • Trafigura Taking Lithium Supply Matters into its Own Hands
  • Where are All the Chairs Now the Music Has Stopped?
  • The Week that Was – May 16-20, 2022
  • CGF – Credit Suisse rates the stock as Neutral

Subscribe to ShareCafe

The daily resource for hands-on investors. Market insights and investment ideas delivered free to your inbox.

Copyright 2020 Informed Investor Pty Ltd ABN 42 162 871 589. All rights reserved.
No portion of this website maybe reproduced, copied or in any way released without written permission.
Share Cafe is a Corporate Authorised Representative (001283561) of Sequoia Asset Management Pty Limited who holds an Australian Financial Services Licence (Number: 341506)

Terms of Service | Privacy Policy | Contact | Advertise

DOWNLOAD RESEARCH REPORT

4Q reveals more focus on profit and cash flow

• LBY’s 4Q FY22 quarterly activities update showed continued solid growth in top line metrics, albeit slowing, with GMV of NZ$203m (+26% on pcp) and income of NZ$12.1m (+23% on pcp).
• Net Transaction Margin (NTM) disappointed at -0.5%, due to further increase in credit losses from 4.0% to 4.9% of GMV. However, new fraud and credit risk management tools have seen losses recover materially with NTM back to 1.2% in March and LBY is confident of further recovery in coming months.

    SMSFBrokerFinancial Adviser

    Please prove you are human by selecting the Tree.

    DOWNLOAD RESEARCH REPORT

    Signs MOU with Ford Company – Kachi is now sold out!

    Lake Resources (LKE. ASX) – LKE has signed two non-binding MOU’s in the space of 10 days. Ford Company (Ford) has signed an MOU for ~25,000t/year and last week Hanwa, a Japanese commodity trader signed a MOU for up to 25,000t/year. Subject to execution, this is an amazing feat as Ford and Hanwa are prepared to enter into longer-term strategic partnerships with LKE. Commercial negotiations are still ongoing but are expected, especially if Ford & Hanwa inject new equity into LKE, to further de-risk the project financing & thus ensure LKE and Kachi are fully funded.

      SMSFBrokerFinancial Adviser

      Please prove you are human by selecting the Heart.

      DOWNLOAD RESEARCH REPORT

      Strategic Vanadium-battery growth with Titanium & Iron earnings resiliency

      TNG Ltd is an ASX-listed technology owner and developer of the world-class Mount Peake near-surface vanadiferous titanomagnetite deposit. To unlock value, TNG will concentrate ore from its central Northern Territory mine for processing through its patented TIVAN® process produce three premium quality revenue streams: hi-purity vanadium pentoxide (V2O5) for steel alloys and Vanadium Redox Flow batteries, a quality titanium pigment for paints and a premium steel input with >64%Fe iron ore fines.

        SMSFBrokerFinancial Adviser

        Please prove you are human by selecting the Star.

        Promising exploration and development update while SOP prices continue to rise

        Two recent gravity surveys have considerably exceeded expectations and revealed potential for extensions to the existing MRE at Lake Throssell, plus a material growth opportunity at Lake Yeo. This reinforces the potential for a multi-decade, Tier-1 SOP production hub based around Lake Throssell.

        TMG is currently completing work towards the PFS due early 2023, including drilling to start in Q3 2022, evaporation trials and permitting activities. Results from these programs will support the PFS and any future resource upgrade.

        Benchmark SOP prices have risen to ~US$940/t due to recent geopolitical developments. The Oct 2021 Scoping Study assumed a SOP price of US$550/t and contained a sensitivity analysis showing every 10% increase in price drives a +$144m increase in the project NPV of $364m. The c.70% increase above the Scoping Study thus implies a project NPV of ~$1.4bn.

        DOWNLOAD RESEARCH REPORT

          SMSFBrokerFinancial Adviser

          Please prove you are human by selecting the Cup.

          DOWNLOAD RESEARCH REPORT

          Biopharmas Hit, but Buying Opportunities Created

          The news being reported about the performance of biotechnology has been dour, to say the least, for some time now. Those dour articles have been deserved with the iShares Biotechnology Exchange-Traded Fund down 25% and the SPDR® S&P® Biotech ETF is down 45% from their highs. However, those articles are backward-looking, and successful investors need to be looking forward.

          Recently, however, an article in Nature Reviews Drug Discovery caught our eye which we believe should point the way forward for the vast majority of Australian biotechnology investors. This article indicates that, at least, two companies, Antisense Therapeutics (ANP) and Kazia Therapeutics (KZA), are right in the sweet spot in terms of the future of drug development.

            SMSFBrokerFinancial Adviser

            Please prove you are human by selecting the Truck.

            DOWNLOAD RESEARCH REPORT

            Biopharmas Hit, but Buying Opportunities Created

            The news being reported about the performance of biotechnology has been dour, to say the least, for some time now. Those dour articles have been deserved with the iShares Biotechnology Exchange-Traded Fund down 25% and the SPDR® S&P® Biotech ETF is down 45% from their highs. However, those articles are backward-looking, and successful investors need to be looking forward.

            Recently, however, an article in Nature Reviews Drug Discovery caught our eye which we believe should point the way forward for the vast majority of Australian biotechnology investors. This article indicates that, at least, two companies, Antisense Therapeutics (ANP) and Kazia Therapeutics (KZA), are right in the sweet spot in terms of the future of drug development.

              SMSFBrokerFinancial Adviser

              Please prove you are human by selecting the Truck.

              DOWNLOAD RESEARCH REPORT

              Coal prices up, debt down – It’s payback time

              Strong 1H22 but the real story unfolds in 2H22.

              TerraCom made two announcements to the ASX on the 28th February – the first was their 2021 Half Year 2021 result which indicated that TER continues to report strong operating metrics as well as enjoying buoyant thermal coal markets which is allowing them to pay down debt at an accelerated pace.

                SMSFBrokerFinancial Adviser

                Please prove you are human by selecting the Key.

                DOWNLOAD RESEARCH REPORT

                Hitting goals – Making four material announcements

                We initiated on Magnis Energy Technologies (MNS.ASX) in December 2021 and since then, MNS has made four material announcements. Firstly; a conditional offtake contract for 600,000t of graphite concentrate from the Tanzanian Nachu Project (net 100%) was signed with Traxys, a global
                commodities merchant with annual revenue of ~US$6Bn; secondly; semi autonomous production has started at battery gigafactory iM3NY, thirdly;
                exciting Extra Fast Charge battery tests were reported and most recently, the game changing launch of the Lithium Slim Energy Reserve battery platform, which supports C4V’s growing EFC capability.

                  SMSFBrokerFinancial Adviser

                  Please prove you are human by selecting the Car.

                  DOWNLOAD RESEARCH REPORT

                  Increasing our Target

                  Despite the lower realised oil and gas price, which fell by 5.4% and 19.7% respectively in August, Calima managed to show improvement in its key business metrics.

                  We expect higher production in November due to the contribution by the new Thorsby wells which will be drilled in August/September which will see Calima meet its 2021 production guidance of 4,500 boe/d.

                    SMSFBrokerFinancial Adviser

                    Please prove you are human by selecting the Cup.

                    DOWNLOAD RESEARCH REPORT

                    Emerging Financial Wealth Advisory Group

                    WT Financial Group Limited (WTL) is a growing diversified financial services company, founded in 2010 and listed on the Australian Stock Exchange (ASX) in 2015. Its advice and product offerings are delivered primarily through a group of independent financial advisers operating as authorised representatives of WTL under its Wealth Today Pty Ltd (Wealth Today) and Sentry Group Pty Ltd (Sentry Group) dealer group operations. It has around 275 advisers across more than 200 financial advice practices Australia-wide. It also operates a direct-to-consumer operation under its Spring Financial Group brand.

                      SMSFBrokerFinancial Adviser

                      Please prove you are human by selecting the Heart.

                      DOWNLOAD RESEARCH REPORT
                      Immutep Taking the Fight to Cancer

                      In May 2021, Corporate Connect analyst Marc Sinatra published a comprehensive research report on ASX-listed biotech Immutep Ltd (ASX: IMM). So impressed was he with IMM that Corporate Connect felt it imperative that a follow-up report be released placing a valuation on the company, because the market was not seeing the vast potential of eftilagimod alpha (efti).

                      This follow-up report has been released today. Using comparables, after adding cash back to their EV estimate and dividing by the total number of issued shares, Corporate Connect now places the fair value of an Immutep share at $A2.20.

                        SMSFBrokerFinancial Adviser

                        Please prove you are human by selecting the Star.

                        DOWNLOAD RESEARCH REPORT

                        Phillips 66 to acquire 16% in NVX – 12-month target price rises 7% through project de-risking

                        Phillips 66 (PSX) has entered into an agreement with NVX to acquire 77.9m new shares for US$150m (A$203m). PSX is the worlds largest producer of speciality petroleum coke a precursor for battery grade synthetic graphite anode materials found with an Enterprise Value of US$47.5Bn and assets of US$57Bn.

                          SMSFBrokerFinancial Adviser

                          Please prove you are human by selecting the Truck.

                          DOWNLOAD RESEARCH REPORT

                          Market leading lifelong learning platform technology company in Australia and SE Asia

                          PayGroup (PYG) delivers multi-country BPO services and cloud SaaS HCM solutions, assisting companies to manage employees in multiple, complex jurisdictions. The company has many growth opportunities, including new clients, new jurisdictions, new products, partner expansion, and new revenue sources. PYG’s scalable business model allows operating leverage and with savings from in-housing third party technology, support margin expansion.

                            SMSFBrokerFinancial Adviser

                            Please prove you are human by selecting the Star.

                            DOWNLOAD RESEARCH REPORT

                            Market leading lifelong learning platform technology company in Australia and SE Asia

                            OpenLearning (OLL) is a higher education technology company that operates a scalable online learning platform through a software-as-a-service (SaaS) business model and provides a global marketplace of high quality courses for learners of all levels. Its primary customers are education providers based in Australia and South-East Asia (primarily Malaysia). OLL started operations in Australia in 2012 and expanded to Malaysia in 2015, Singapore in 2018, and recently also Indonesia.

                              SMSFBrokerFinancial Adviser

                              Please prove you are human by selecting the House.